c.) Develop, update and promote, evidence-based treatment standards and guidelines for all adult and childhood cancer, of all stages, including the management of late effects; d.) Develop innovative and cost-effective cancer care service models for effectively delivering integrated cancer care in the most appropriate settings and improve patient care flow from primary to tertiary care; e.) Develop clearly defined patient care pathways and evidence-based standards of care for the network of cancer centers; f.) Set quality and accreditation standards for oncology focused health service facilities, ethical cancer research, health care providers, medical professionals and allied health care professionals; g.) Monitor and assess the implementation of prioritized packages of cancer services for all ages and all stages of cancer, ensuring that they are provided in an equitable, affordable and sustainable manner, at all levels of care; h.) Recommend responsive and proactive medicine access programs, including improvements of core systems and process related to: 1.) Availability and affordability of quality, safe, and effective medicines; 2.) Increased access to cost effective vaccinations to prevent infections associated with cancer; 3.) Diagnostics for cancer; 4.) Innovative medicines and technologies; and 5.) Compassionate use of protocols, as necessary; i.) Establish mechanisms and platforms for multisectoral and multistakeholder collaborations, coordination, and cooperation, especially in health promotion, disease prevention, capacity development, education, training and learning information and communication, social mobilization and resource mobilization; j.) Establish mechanisms and platforms for patient, family and community engagement, especially on protection and promotion of the rights of patients, survivors and their families and their active involvement in multidisciplinary patient care, patient navigation and survivors’ follow-up care; k.) Strengthen linkages with local and international organizations for possible partnerships in treatment and management of challenging and rare cases, education, training and learning, advocacy, research, resource mobilization and funding assistance; l.) Institute the provision of child life services in all appropriate hospitals and facilties; m.) Establish a system for program review, monitoring and evaluation, inclusive of financial aspects, and submit an annual report and recommendation to the Secretary of Health on the progress, accomplishments and implementation challenges encountered; and n.) Secure from government agencies and other stakeholders, recommendations, and plans pertinent to the respective mandates of the agencies and other stakeholders for the implementation of the provisions of this Act. SECTION 8. Personal Complement. To ensure the effective implementation of this Act, the personnel complement for the Cancer Programs in the Disease Prevention and Control Bureau of the DOH shall be increased. A Division Chief for Cancer Control Program shall be designated to provide operational, leadership, undertake coordination with program stakeholders and ensure effective and sustainable implementation of the National Integrated Cancer Control Program. The Secretary of Health shall, in coordination with the Secretary of Budget and Management (DBM), create the additional plantilla positions for health personnel required in the program. ARTICLE III QUALITY HEALTH CARE SYSTEMS SECTION 9. Cancer Care Infrastructure. – The DOH, local government units (LGUs), and other government agencies concerned shall strengthen the capability of public health systems and facilities, provision of services and continuum of care, through the following key activities: a.) Allocate adequate resources for investments in health facility renovation or upgrade, inclusive of technologies and equipment for use in cancer treatment and care from cancer diagnosis to cancer rehabilitation; b.) Develop robust and effective patient referral pathways across levels of health service delivery;

Select target paragraph3